Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 9, Issue 3, 2009, Pages 459-462

  Tatoulis, James ^a,b   Theodore, Sanjay ^a   Meswani, Manish ^a   Wynne, Rochelle ^a   Hon Yap, Cheng ^a   Powar, Nikunj ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Novoseven; Recombinant activated factor seven; Refractory bleeding

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; MALE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOCYTE COUNT; TREATMENT OUTCOME;

BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; ERYTHROCYTE TRANSFUSION; FACTOR VIIA; FEMALE; FIBRINOGEN; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; REOPERATION; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 69249156464     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.204735     Document Type: Article

References (15)

1. Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM. Comprehensive Canadian review of the off-label use of recombinant activated factorVII in cardiac surgery. Circulation 2008;118:331-338.
2. Spinella PC, Perkins JG, McLaughlin DF, Niles SE, Grathwohl KW, Beekley AC, Salinas J, Mehta S, Wade CE, Holcomb JB. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma 2008;64:286-293. (Pubitemid 351640428)
3. Felfernig M, Huepfl M. Experience of recombinant activated factor VII (NovoSeven) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients. Clin Neurol Neurosurg 2008;110:227-232.
4. Tien HC, Gough MR, Farrell R, Macdonald J. Successful use of recombinant activated coagulation factor VII in a patient with massive hemoptysis from a penetrating thoracic injury. Ann Thorac Surg 2007;84:1373-1374. (Pubitemid 47432649)
5. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, Buller HR, Levi M. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 2003;361:201-205. (Pubitemid 36126219)
6. Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De Cicco G, Bille G, Stefano P, Gensini GF. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis. Eur J Cardiothorac Surg 2008;33:64-71. (Pubitemid 350266356)
7. Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. Ann Thorac Surg 2008;85:836-844. (Pubitemid 351255532)
8. Hyllner M, Houltz E, Jeppsson A. Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery. Eur J Cardiothorac Surg 2005;28:254-258. (Pubitemid 41020693)
9. Levi M, Peters M, Buller HR. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 2005;33:883-890. (Pubitemid 40504401)
10. Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Recombinant activated factor VII in cardiac surgery: a systematic review. Ann Thorac Surg 2007;83:707-714. (Pubitemid 46138055)
11. Bishop CV, Renwick WE, Hogan C, Haeusler M, Tuckfield A, Tatoulis J. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery. Ann Thorac Surg 2006;81:875-879. (Pubitemid 43247653)
12. Karkouti K, Cohen MM, McCluskey SA, Sher GD. A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass graft surgery. Transfusion 2001;41:1193-1203. (Pubitemid 33000953)
13. Despotis G, Avidan M, Lublin DM. Off-label use of recombinant factor VIIA concentrates after cardiac surgery. Ann Thorac Surg 2005;80:3-5. (Pubitemid 40840172)
14. Karkouti K, Beattie WS, Wijeysundera DN, Yau TM, McCluskey SA, Ghannam M, Sutton D, Van Rensberg A, Karsky J. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. Transfusion 2005;45:26-34.
15. Raivio P, Suojaranta-Ylinen R, Kuitunen AH. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 2005;80:66-71. (Pubitemid 40840184)